Literature DB >> 28689967

Cyclodextrin-Modified inorganic materials for the construction of nanocarriers.

Giovanna Cutrone1, Juan M Casas-Solvas1, Antonio Vargas-Berenguel2.   

Abstract

Inorganic nanoparticles, such as gold, silver, quantum dots and magnetic nanoparticles, offer a promising way to develop multifunctional nanoparticles for biomedical applications. Such nanoparticles have the potential to combine in a single, stable construct various functionalities, simultaneously providing imaging abilities, thermal therapies and the ability to deliver drugs in a targeted fashion. An approach for providing drug loading abilities to these inorganic nanoparticles consists in the modification of their surface with a coating of cyclodextrins, and thereby endowing the nanoparticles with the potential of functioning as drug nanocarriers. This review presents the advances carried out in the preparation of cyclodextrin-contained gold, silver, quantum dot and magnetic nanoparticles as well as their applications as drug nanocarriers. The nanoparticle surface can be modified incorporating cyclodextrin moieties, (i) in situ during the synthesis of the nanoparticles, either using the cyclodextrin as reducing agent or as stabilizer; or (ii) in a post-synthetic stage. The cyclodextrin coating contributes to provide biocompatibility to the nanoparticles and to reduce their cytotoxicity. Cyclodextrin-modified nanoparticles display a multivalent presentation of quasi-hydrophobic cavities that enables, not only drug loading in a non-covalent manner, but also the non-covalent assembly of targeting motifs and optical probes. This paper also provides an overview of some of the reported applications including the in vitro studies and, to a lesser extent, in vivo studies on the drug-loaded nanoparticles behavior.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cyclodextrin; Drug nanocarriers; Gold nanoparticles; Magnetic nanoparticles; Multifunctional nanocarriers; Quantum dots; Silver nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 28689967     DOI: 10.1016/j.ijpharm.2017.06.080

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.

Authors:  Maurizio Viale; Rita Tosto; Valentina Giglio; Giuseppe Pappalardo; Valentina Oliveri; Irena Maric; Maria Addolorata Mariggiò; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2018-12-17       Impact factor: 3.850

2.  Mechanically interlocked functionalization of monoclonal antibodies.

Authors:  Krzysztof P Bzymek; James W Puckett; Cindy Zer; Jun Xie; Yuelong Ma; Jeremy D King; Leah H Goodstein; Kendra N Avery; David Colcher; Gagandeep Singh; David A Horne; John C Williams
Journal:  Nat Commun       Date:  2018-04-20       Impact factor: 14.919

3.  Bisphenol A Adsorption on Silica Particles Modified with Beta-Cyclodextrins.

Authors:  Stefan Bucur; Aurel Diacon; Ionel Mangalagiu; Alexandra Mocanu; Florica Rizea; Adrian Dinescu; Adi Ghebaur; Aurelian Cristian Boscornea; Georgeta Voicu; Edina Rusen
Journal:  Nanomaterials (Basel)       Date:  2021-12-23       Impact factor: 5.076

Review 4.  State of the Art on Green Route Synthesis of Gold/Silver Bimetallic Nanoparticles.

Authors:  Angela Scala; Giulia Neri; Nicola Micale; Massimiliano Cordaro; Anna Piperno
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

5.  β-Cyclodextrin/Isopentyl Caffeate Inclusion Complex: Synthesis, Characterization and Antileishmanial Activity.

Authors:  Carine S F Marques; Nathalia S Barreto; Simone S C de Oliveira; André L S Santos; Marta H Branquinha; Damião P de Sousa; Mayara Castro; Luciana N Andrade; Matheus M Pereira; Classius F da Silva; Marco V Chaud; Sona Jain; Alini T Fricks; Eliana B Souto; Patricia Severino
Journal:  Molecules       Date:  2020-09-12       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.